277 related articles for article (PubMed ID: 30518941)
1. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy.
Kaur US; Shet A; Rajnala N; Gopalan BP; Moar P; D H; Singh BP; Chaturvedi R; Tandon R
Sci Rep; 2018 Dec; 8(1):17679. PubMed ID: 30518941
[TBL] [Abstract][Full Text] [Related]
2. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
Sessa L; Reddel S; Manno E; Quagliariello A; Cotugno N; Del Chierico F; Amodio D; Capponi C; Leone F; Bernardi S; Rossi P; Putignani L; Palma P
AIDS; 2019 May; 33(6):1001-1011. PubMed ID: 30946154
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
6. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
[TBL] [Abstract][Full Text] [Related]
7. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study.
Sainz T; Gosalbes MJ; Talavera-Rodríguez A; Jimenez-Hernandez N; Prieto L; Escosa L; Guillén S; Ramos JT; Muñoz-Fernández MÁ; Moya A; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708743
[TBL] [Abstract][Full Text] [Related]
9. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
[TBL] [Abstract][Full Text] [Related]
11. Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance.
Munjoma PT; Chandiwana P; Wyss J; Mazhandu AJ; Jordi SBU; Gutsire R; Katsidzira L; Yilmaz B; Misselwitz B; Duri K
Front Immunol; 2023; 14():1280262. PubMed ID: 38045684
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
13. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease.
Kehrmann J; Menzel J; Saeedghalati M; Obeid R; Schulze C; Holzendorf V; Farahpour F; Reinsch N; Klein-Hitpass L; Streeck H; Hoffmann D; Buer J; Esser S;
J Infect Dis; 2019 Jan; 219(3):497-508. PubMed ID: 30202890
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota Diversity in HIV-Infected Patients on Successful Antiretroviral Treatment is Linked to Sexual Preferences but not CD4 Nadir.
Jabłonowska E; Strzelczyk J; Piekarska A; Wójcik-Cichy K
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):14. PubMed ID: 33983543
[TBL] [Abstract][Full Text] [Related]
16. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men.
Armstrong AJS; Shaffer M; Nusbacher NM; Griesmer C; Fiorillo S; Schneider JM; Preston Neff C; Li SX; Fontenot AP; Campbell T; Palmer BE; Lozupone CA
Microbiome; 2018 Nov; 6(1):198. PubMed ID: 30396369
[TBL] [Abstract][Full Text] [Related]
17. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon.
Abange WB; Martin C; Nanfack AJ; Yatchou LG; Nusbacher N; Nguedia CA; Kamga HG; Fokam J; Kennedy SP; Ndjolo A; Lozupone C; Nkenfou CN
Sci Rep; 2021 Apr; 11(1):7666. PubMed ID: 33828220
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the intestinal microbiota in MSM with HIV infection.
Fu Y; Ke S; Tang G; Guo Q; Guo Q; Wang Z; Leng R; Fan Y
BMC Microbiol; 2024 Jun; 24(1):192. PubMed ID: 38831399
[TBL] [Abstract][Full Text] [Related]
20. Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a
Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sönnerborg A; Neogi U
J Virol; 2021 Aug; 95(18):e0047921. PubMed ID: 34232744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
